![Richard Steinhart](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Steinhart
Directeur/Bestuurslid bij
ACTINIUM PHARMACEUTICALS, INC.
Vermogen: 22 510 $ op 31-10-2026
Profiel
Mr. Richard I.
Steinhart is an Independent Director at Atossa Therapeutics, Inc. and an Independent Director at Actinium Pharmaceuticals, Inc. He is on the Board of Directors at Atossa Therapeutics, Inc. and Actinium Pharmaceuticals, Inc. Mr. Steinhart was previously employed as a Senior VP, Chief Financial & Accounting Officer by BioXcel Therapeutics, Inc., a Chief Financial Officer & Vice President by Remedy Pharmaceuticals, Inc., a CFO, Secretary, Treasurer & Senior VP-Finance by MELA Sciences, Inc., an Independent Director by Manhattan Pharmaceuticals, Inc., a Managing Director by Forest Street Capital, LLC, a Chief Financial Officer & Vice President by Emisphere Technologies, Inc., a Chief Financial Officer & General Partner by CW Group, Inc., and a Managing Director by SAE Ventures.
He received his undergraduate degree from Pace University and an MBA from Pace University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 12-05-2026 | 10.000 ( 0,1% ) | 21 700 $ | 31-10-2026 | |
| 02-10-2026 | 316 ( 0% ) | 468 $ | 31-10-2026 | |
| 15-06-2026 | 26.335 ( 0,18% ) | 342 $ | 31-10-2026 |
Actieve functies van Richard Steinhart
| Bedrijven | Functie | Begin |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 08-11-2013 |
| ATOSSA THERAPEUTICS, INC. | Directeur/Bestuurslid | 03-03-2014 |
Eerdere bekende functies van Richard Steinhart
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Financieel Directeur/CFO | 31-10-2026 |
Remedy Pharmaceuticals, Inc.
 Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company that develops molecule drugs for acute central nervous system disorders | Financieel Directeur/CFO | 01-04-2017 |
| STRATA SKIN SCIENCES, INC. | Financieel Directeur/CFO | 31-12-2013 |
| TG THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-01-2012 |
Forest Street Capital, LLC | Corporate Officer/Principal | 24-04-2006 |
Opleiding van Richard Steinhart
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
71
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical and drug delivery company | Health Technology |
TG Therapeutics, Inc.
 TG Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
STRATA Skin Sciences, Inc.
 STRATA Skin Sciences, Inc. Medical SpecialtiesHealth Technology Manufactures dermatology treatment products | Health Technology |
Atossa Therapeutics, Inc.
 Atossa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics and delivery methods for the treatment of breast cancer & other breast conditions | Health Technology |
CW Group, Inc.
 CW Group, Inc. Investment ManagersFinance CW Group invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Pace University
 Pace University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Remedy Pharmaceuticals, Inc.
Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company that develops molecule drugs for acute central nervous system disorders | Health Technology |
Actinium Pharmaceuticals, Inc.
 Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
Forest Street Capital, LLC | |
SAE Ventures | |
BioXcel Therapeutics, Inc.
 BioXcel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops transformative medicines in neuroscience and immuno-oncology | Health Technology |
